Sign In
Buy ALKS
$42.76
+1.44 (+3.48%)
At Close: Jun 03, 2026
Alkermes (ALKS) Moves to Buy: Rationale Behind the Upgrade
12:47pm, Tuesday, 22'nd Dec 2020
Alkermes (ALKS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Alkermes Shares Jumped Higher Today
02:58pm, Thursday, 10'th Dec 2020
The biotech has a plan to increase profitability.
Alkermes Reschedules Third Quarter 2020 Financial Results Conference Call to 10:30 a.m. ET
10:24am, Thursday, 29'th Oct 2020
DUBLIN, Oct. 29, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announces that the conference call to discuss the company's third quarter financial results is rescheduled due to technical difficulti
Entera Osteoporosis Trial, And Other News: The Good, Bad And Ugly Of Biopharma
06:48am, Monday, 24'th Aug 2020
Entera Bio reports encouraging data from osteoporosis trial. Alkermes progresses Phase 2 trial for ALKS 4230.
Alkermes plc (Nasdaq: ALKS) today announced the initiation of ARTISTRY-3, a new phase 2 study to evaluate the clinical and immunologic effects of ALKS 4230 monotherapy on the tumor microenvironment of
Alkermes plc (Nasdaq: ALKS) today announced the publication of results from the phase 3 ENLIGHTEN-2 clinical trial of ALKS 3831 (olanzapine/samidorphan) in the peer-reviewed publication, American Jour
ANIK or ALKS: Which Is the Better Value Stock Right Now?
03:40pm, Wednesday, 05'th Aug 2020
ANIK vs. ALKS: Which Stock Is the Better Value Option?
10 Biggest Biotechnology Companies
11:32pm, Thursday, 30'th Jul 2020
With Novo Nordisk at the top of the list, these are the 10 biggest biotechnology companies by 12-month trailing revenue.
Alkermes' (ALKS) Q2 Earnings & Revenues Surpass Estimates
03:08pm, Thursday, 30'th Jul 2020
Alkermes' (ALKS) earnings decline year over year in the second quarter of 2020.
Estimating The Intrinsic Value Of Alkermes plc (NASDAQ:ALKS)
12:08pm, Thursday, 30'th Jul 2020
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Alkermes plc...
Alkermes PLC (ALKS) Q2 2020 Earnings Call Transcript
09:30pm, Wednesday, 29'th Jul 2020
ALKS earnings call for the period ending June 30, 2020.
Alkermes plc (ALKS) CEO Richard Pops on Q2 2020 Results - Earnings Call Transcript
04:20pm, Wednesday, 29'th Jul 2020
Alkermes plc (NASDAQ:ALKS) Q2 2020 Results Conference Call July 29, 2020 08:00 ET Company Participants Sandra Coombs - Vice President, Investor Relations Richard Pops - Chairman and Chief Executive Of
Alkermes (ALKS) Beats Q2 Earnings and Revenue Estimates
12:45pm, Wednesday, 29'th Jul 2020
Alkermes (ALKS) delivered earnings and revenue surprises of 700.00% and 3.61%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Alkermes: Q2 Earnings Insights
11:40am, Wednesday, 29'th Jul 2020
Shares of Alkermes (NASDAQ:ALKS) rose 2.5% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 33.33% year over year to $0.06, which beat the est
Alkermes plc 2020 Q2 - Results - Earnings Call Presentation
09:31am, Wednesday, 29'th Jul 2020
The following slide deck was published by Alkermes plc in conjunction with their 2020 Q2 earnings call.
